| |
| |
|
| Insider
Information: |
Perry Mark L |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
275,485 |
|
|
Indirect Shares
|
123,600 |
|
|
| Direct
Value |
$27,544,677 |
|
|
|
Indirect Value
|
$129,726,852 |
|
|
| Total
Shares |
399,085 |
|
|
| Total
Value |
$157,271,529 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 266.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP Operations |
2004-02-03 |
196,040 |
2004-02-03 |
5,600 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
Director |
2006-09-28 |
65,833 |
2006-09-28 |
0 |
Premium* |
|
|
NVIDIA Corporation |
NVDA |
Director |
2024-04-02 |
13,612 |
2024-04-02 |
118,000 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2022-10-05 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
51 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABIO |
Nuvelo Inc |
Director |
– • – |
2006-09-28 |
4 |
OE |
$6.50 |
$596,989 |
D/D |
65,833 |
65,833 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2015-08-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,428 |
|
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2015-08-17 |
4 |
B |
$20.00 |
$100,000 |
D/D |
5,000 |
26,428 |
2.39 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2020-05-12 |
4 |
S |
$74.01 |
$4,186,061 |
D/D |
(53,600) |
26,428 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2020-05-12 |
4 |
OE |
$18.85 |
$1,181,500 |
D/D |
53,600 |
80,028 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2020-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,800 |
31,228 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2021-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,037 |
34,265 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,600 |
37,865 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2022-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,865) |
0 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-08-05 |
4 |
S |
$65.00 |
$2,757,820 |
D/D |
(42,344) |
194,039 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-08-05 |
4 |
OE |
$5.72 |
$663,815 |
D/D |
54,000 |
236,383 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-08-06 |
4 |
S |
$61.17 |
$618,475 |
D/D |
(10,000) |
194,039 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-08-06 |
4 |
OE |
$14.59 |
$145,938 |
D/D |
10,000 |
204,039 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-10-31 |
4 |
S |
$54.28 |
$2,396,250 |
D/D |
(44,000) |
194,039 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2003-10-31 |
4 |
OE |
$14.59 |
$642,127 |
D/D |
44,000 |
238,039 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2004-02-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
300 |
196,040 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2004-02-03 |
4 |
S |
$56.50 |
$2,813,747 |
D/D |
(49,716) |
196,340 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2004-02-03 |
4 |
OE |
$14.59 |
$767,626 |
D/D |
52,000 |
246,056 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP Operations |
• – – |
2004-02-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
300 |
5,600 |
|
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2008-01-18 |
4 |
OE |
$8.47 |
$423,500 |
D/D |
50,000 |
50,000 |
0 |
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2011-04-06 |
4 |
S |
$17.41 |
$3,046,330 |
D/D |
(175,000) |
50,000 |
0 |
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2011-04-06 |
4 |
OE |
$8.47 |
$1,482,250 |
D/D |
175,000 |
225,000 |
0 |
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2012-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
16,281 |
66,281 |
0 |
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2013-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
17,307 |
17,307 |
0 |
- |
|
| NVDA |
NVIDIA Corporation |
Director |
– • – |
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
12,208 |
45,796 |
0 |
- |
|
51 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
